0001094038-16-000005.txt : 20160825 0001094038-16-000005.hdr.sgml : 20160825 20160824181930 ACCESSION NUMBER: 0001094038-16-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160825 DATE AS OF CHANGE: 20160824 EFFECTIVENESS DATE: 20160825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TAPIMMUNE INC CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-269511 FILM NUMBER: 161850161 BUSINESS ADDRESS: STREET 1: 50 N LAURA STREET STREET 2: SUITE 2500 CITY: JACKSONVILLE STATE: FL ZIP: 98102 BUSINESS PHONE: (206) 504-7278 MAIL ADDRESS: STREET 1: 50 N LAURA STREET STREET 2: SUITE 2500 CITY: JACKSONVILLE STATE: FL ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 FORMER COMPANY: FORMER CONFORMED NAME: EDUVERSE COM DATE OF NAME CHANGE: 19990827 D 1 primary_doc.xml X0707 D LIVE 0001094038 TAPIMMUNE INC 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL FLORIDA 98102 (206) 504-7278 NEVADA GENEMAX CORP EDUVERSE COM Corporation true Glynn Wilson 50 N Laura Street Suite 2500 Jacksonville FL FLORIDA 98102 Executive Officer Director John Bonfiglio 50 N Laura Street Suite 2500 Jacksonville FL FLORIDA 98102 Executive Officer Director David Laskow-Pooley 50 N Laura Street Suite 2500 Jacksonville FL FLORIDA 98102 Director Mark Reddish 50 N Laura Street Suite 2500 Jacksonville FL FLORIDA 98102 Director Sherry Grisewood 50 N Laura Street Suite 2500 Jacksonville FL FLORIDA 98102 Director Frederick Wasserman 50 N Laura Street Jacksonville FL FLORIDA 98102 Director Biotechnology No Revenues 06b false 2016-08-11 false true true true false 0 GP Nuremenkari Inc. 153480 None None 18 East 41st Street Suite 1902 New York NY NEW YORK 10017 NY NEW YORK false Indefinite 0 Indefinite The Issuer and the holders of warrants entered into an amendment to their warrants for additional consideration consisting of shares of common stock and additional warrants to purchase common stock. false 11 245000 0 0 false TAPIMMUNE INC /s/ Glynn Wilson Glynn Wilson, PH.D. Chief Executive Officer and Director 2016-08-22